PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human CCL23 (MPIF-1) (Arg46-Asn120) (carrier-free), 10 μg
Recombinant Human CCL23 (MPIF-1) (Arg46-Asn120) (carrier-free), 100 μg
Recombinant Human CCL23 (MPIF-1) (Arg46-Asn120) (carrier-free), 25 μg
Recombinant Human CCL23 (MPIF-1) (Arg46-Asn120) (carrier-free), 500 μg
Recombinant Human CCL24 (Eotaxin-2) (carrier-free), 10 μg
Recombinant Human CCL24 (Eotaxin-2) (carrier-free), 100 μg
Recombinant Human CCL24 (Eotaxin-2) (carrier-free), 25 μg
Recombinant Human CCL25 (TECK) (carrier-free), 10 μg
Recombinant Human CCL25 (TECK) (carrier-free), 100 μg
Recombinant Human CCL25 (TECK) (carrier-free), 25 μg
Recombinant Human CCL25 (TECK) (carrier-free), 500 μg
Recombinant Human CCL27 (CTACK) (carrier-free), 10 μg
Recombinant Human CCL27 (CTACK) (carrier-free), 100 μg
Recombinant Human CCL28 (MEC) (carrier-free), 10 μg
Recombinant Human CCL28 (MEC) (carrier-free), 100 μg
Recombinant Human CCL28 (MEC) (carrier-free), 25 μg